603259 药明康德
已收盘 03-24 15:00:00
资讯
新帖
简况
港股医药生物板块持续走高 药明康德涨超10%
南方财经网 · 03-24 15:19
港股医药生物板块持续走高 药明康德涨超10%
瑞银：药明康德(02359)上季纯利略胜预期 升目标价至154.1港元
智通财经 · 03-24 11:50
瑞银：药明康德(02359)上季纯利略胜预期 升目标价至154.1港元
高盛：药明康德(02359)2026年指引符预期 目标价144.6港元及“买入”评级
智通财经 · 03-24 11:43
高盛：药明康德(02359)2026年指引符预期 目标价144.6港元及“买入”评级
港股异动 | 药明康德(02359)绩后涨超6% 全年纯利同比实现翻倍 拟派发现金红利超47亿元
智通财经 · 03-24 09:37
港股异动 | 药明康德(02359)绩后涨超6% 全年纯利同比实现翻倍 拟派发现金红利超47亿元
中期分红常态化！药明康德(02359)连续第二年官宣中期分红 预约26年现金分红总额超57亿
智通财经 · 03-24 07:55
中期分红常态化！药明康德(02359)连续第二年官宣中期分红 预约26年现金分红总额超57亿
牛市早报｜国家发展改革委对国内成品油价格采取临时调控措施
澎湃新闻 · 03-24 07:52
牛市早报｜国家发展改革委对国内成品油价格采取临时调控措施
港股早知道 | 药明康德去年净利同比增长105.2%；新股泽景股份、凯乐士科技今日挂牌
智通财经 · 03-24 07:30
港股早知道 | 药明康德去年净利同比增长105.2%；新股泽景股份、凯乐士科技今日挂牌
【财闻联播】药明康德2025年业绩出炉！中国银行：加强贵金属市场风险防范
券商中国 · 03-23 20:50
【财闻联播】药明康德2025年业绩出炉！中国银行：加强贵金属市场风险防范
药明康德：关于续聘2026年度会计师事务所的公告
证券日报 · 03-23 20:29
药明康德：关于续聘2026年度会计师事务所的公告
药明康德：拟使用不超180亿元闲置自有资金进行现金管理
每日经济新闻 · 03-23 17:59
药明康德：拟使用不超180亿元闲置自有资金进行现金管理
定调全年！药明康德(02359)预计2026年收入将达到513~530亿元
智通财经 · 03-23 17:59
定调全年！药明康德(02359)预计2026年收入将达到513~530亿元
CRDMO战略兑现！药明康德全年营收454亿：以“史上最佳季度”回馈股东
智通财经 · 03-23 17:55
CRDMO战略兑现！药明康德全年营收454亿：以“史上最佳季度”回馈股东
药明康德(02359)将派发末期股息每10股15.7927元
智通财经 · 03-23 17:11
药明康德(02359)将派发末期股息每10股15.7927元
药明康德(02359)：建议重选执行董事、非执行董事、独立非执行董事
智通财经 · 03-23 17:07
药明康德(02359)：建议重选执行董事、非执行董事、独立非执行董事
药明康德(02359)：建议变更注册资本为29.84亿元
智通财经 · 03-23 16:54
药明康德(02359)：建议变更注册资本为29.84亿元
药明康德上调股份回购价格上限至每股不超过114.15元
美股速递 · 03-23 16:52
药明康德上调股份回购价格上限至每股不超过114.15元
药明康德：2025年营收454.56亿元，归母净利润191.95亿元
老虎资讯综合 · 03-23 16:49
药明康德：2025年营收454.56亿元，归母净利润191.95亿元
药明康德涨幅扩大至4.9%
每日经济新闻 · 03-17
药明康德涨幅扩大至4.9%
每周股票复盘：药明康德（603259）将召开董事会审议2025年度业绩
证券之星 · 03-15
每周股票复盘：药明康德（603259）将召开董事会审议2025年度业绩
摩根大通增持药明康德H股 持股比例从7.14%升至8.32%
美股速递 · 03-04
摩根大通增持药明康德H股 持股比例从7.14%升至8.32%
加载更多
公司概况
公司名称：
无锡药明康德新药开发股份有限公司
所属行业：
研究和试验发展
上市日期：
2018-05-08
主营业务：
无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务、其他业务。
发行价格：
21.60
{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":93.68,"timestamp":1774335600000,"preClose":87.79,"halted":0,"volume":75717953,"delay":0,"changeRate":0.0671,"floatShares":2473000000,"shares":2984000000,"eps":9.6694,"marketStatus":"已收盘","change":5.89,"latestTime":"03-24 15:00:00","open":90,"high":93.68,"low":90,"amount":6994000000,"amplitude":0.0419,"askPrice":93.69,"askSize":301,"bidPrice":93.68,"bidSize":1128,"shortable":0,"etf":0,"ttmEps":9.6694,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"adjPreClose":87.79,"symbolType":"stock","openAndCloseTimeList":[[1774315800000,1774323000000],[1774328400000,1774335600000]],"highLimit":96.57,"lowLimit":79.01,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2983757155,"isCdr":false,"pbRate":3.51,"roa":"--","peRate":9.688295,"roe":"28.56%","epsLYR":6.7,"committee":0.545431,"marketValue":279518000000,"turnoverRate":0.0306,"status":0,"hkstockBrief":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":113.6,"timestamp":1774339700006,"preClose":102.7,"halted":0,"volume":11849955,"delay":0,"premium":"+6.78"},"floatMarketCap":231697000000},"requestUrl":"/m/hq/s/603259","defaultTab":"news","newsList":[{"id":"2621516300","title":"港股医药生物板块持续走高 药明康德涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621516300","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621516300?lang=zh_cn&edition=full","pubTime":"2026-03-24 15:19","pubTimestamp":1774336740,"startTime":"0","endTime":"0","summary":"南方财经3月24日电，港股医药生物板块持续走高，药明康德、药明合联涨超10%，歌礼制药、君实生物、凯莱英等涨超5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603243682513456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603259","LU0320764599.SGD","159718","LU2045819591.USD","LU2495084118.USD","LU2328871848.SGD","LU0456842615.SGD","LU2488822045.USD","02359","LU1997244956.HKD","LU0708995583.HKD","BK1576","LU1808992512.USD","BK1583","LU1046422090.SGD","LU2242644610.SGD","LU1934453819.USD","BK1141","LU0052750758.USD","BK0216","LU2125910500.SGD","LU1979443071.USD","LU1997245177.USD","LU1969619763.USD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2621037225","title":"瑞银：药明康德(02359)上季纯利略胜预期 升目标价至154.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621037225","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621037225?lang=zh_cn&edition=full","pubTime":"2026-03-24 11:50","pubTimestamp":1774324226,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，基于药明康德去年第四季业绩微调盈利预测，上调收入及毛利率预测，目标价由153.1港元上调至154.1港元，基于现金流折现估值，维持“买入”评级。药明康德管理层指引今年持续经营业务收入增长18%至22%，达513亿至530亿元，大致符合该行预期及市场预测，目标今年经调整非国际财务报告准则净利润率保持稳定及具韧性，资本开支65亿至75亿元，经调整自由现金流105亿至115亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","603259"],"gpt_icon":0},{"id":"2621372980","title":"高盛：药明康德(02359)2026年指引符预期 目标价144.6港元及“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2621372980","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621372980?lang=zh_cn&edition=full","pubTime":"2026-03-24 11:43","pubTimestamp":1774323819,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，高盛发布研报称，药明康德(02359)2025年第四季非国际财务报告准则(non-IFRS)经调整净利润同比增长36.6%，管理层指引2026年收入为513亿至530亿元人民币，同比增长12.9%至16.6%，大致符合预期。现予H股目标价144.6港元及“买入”评级。该行预期投资者将关注积压订单的质量及组成、TIDES业务订单积压的加速步伐，以及在新产能释放和汇率逆风下，利润率的可持续性。该行认为利润率稳定性大致维持不变，受利润率较高的TIDES业务收入贡献提升，以及利润率较低的已终止经营业务贡献减少所支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","603259"],"gpt_icon":0},{"id":"2621392740","title":"港股异动 | 药明康德(02359)绩后涨超6% 全年纯利同比实现翻倍 拟派发现金红利超47亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621392740","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621392740?lang=zh_cn&edition=full","pubTime":"2026-03-24 09:37","pubTimestamp":1774316239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明康德绩后涨超6%，截至发稿，涨6.33%，报109.2港元，成交额1.73亿港元。消息面上，药明康德发布2025年业绩，期内实现营业收入454.56亿元，同比增长15.84%；实现归属于上市公司股东的净利润约191.51亿元，同比增长102.65%。扣除非经常性损益后，公司归母净利润同比增长32.56%。随着业务增长及效率提升，预计2026年经调整自由现金流达到105亿-115亿元。此外，药明康德还提出，预计2026年现金分红派发总额达到57.1亿元，再创历史新高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2045819591.USD","VXUS","LU1934453819.USD","LU0456842615.SGD","LU0708995583.HKD","02359","BK1576","LU2495084118.USD","BK1141","LU2242644610.SGD","LU1997245177.USD","603259","LU2488822045.USD","BK4588","LU0052750758.USD","LU2125910500.SGD","LU2328871848.SGD","BK1583","LU1808992512.USD","LU1979443071.USD","LU1997245094.SGD","BK4585","LU1969619763.USD","BK0216","LU0320764599.SGD","LU1046422090.SGD","LU1997244956.HKD"],"gpt_icon":0},{"id":"2621339740","title":"中期分红常态化！药明康德(02359)连续第二年官宣中期分红 预约26年现金分红总额超57亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2621339740","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621339740?lang=zh_cn&edition=full","pubTime":"2026-03-24 07:55","pubTimestamp":1774310108,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明康德的股东回报机制正迈向新阶段。继2025年首次实施中期分红后，公司有望在2026年延续这一举措，实现连续第二年中期分红。结合年度分红计划，预计2026年现金分红总额将突破57亿元，刷新历史纪录。这意味着，“中期分红”正从一次性的特别举措，转变为公司常态化、可预期的回报机制。上市七年来，药明康德累计通过分红与回购回馈股东超200亿元，占同期净利润比例超40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","LU1997245177.USD","BK4588","BK0216","LU1969619763.USD","LU1979443071.USD","LU0456842615.SGD","VIG","LU0708995583.HKD","LU1046422090.SGD","LU2242644610.SGD","BK1576","LU1997244956.HKD","LU2125910500.SGD","LU0320764599.SGD","LU1808992512.USD","BK4585","02359","LU1934453819.USD","603259","LU2495084118.USD","LU2045819591.USD","LU0052750758.USD","LU2328871848.SGD","BK1583","LU1997245094.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2621357400","title":"牛市早报｜国家发展改革委对国内成品油价格采取临时调控措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2621357400","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621357400?lang=zh_cn&edition=full","pubTime":"2026-03-24 07:52","pubTimestamp":1774309920,"startTime":"0","endTime":"0","summary":" 1、据澎湃新闻，国家发改委3月23日下午发布消息，3月9日国内成品油价格调整以来，受美以伊冲突加剧影响，国际市场原油价格大幅上涨，特别是中东地区原油价格连创历史新高。为减缓国际油价异常上涨带来的冲击，减轻下游用户负担，保障经济平稳运行和社会民生，在保持现行价格机制框架的基础上，对国内成品油价格采取临时调控措施。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-03-24/doc-inhrzumc3588577.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-24/doc-inhrzumc3588577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2328871848.SGD","LU0456842615.SGD","603259","LU1969619763.USD","LU2488822045.USD","LU1979443071.USD","LU1997245177.USD","LU1997244956.HKD","LU1934453819.USD","LU2495084118.USD","BK0216","LU1808992512.USD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2621033841","title":"港股早知道 | 药明康德去年净利同比增长105.2%；新股泽景股份、凯乐士科技今日挂牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2621033841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621033841?lang=zh_cn&edition=full","pubTime":"2026-03-24 07:30","pubTimestamp":1774308631,"startTime":"0","endTime":"0","summary":"股东应占溢利3.45亿港元，较2024年下降约12%。药明康德发布2025年度业绩，归母净利191.95亿元，同比增长105.2%药明康德发布截至2025年12月31日止年度业绩，收入454.56亿元，同比增长15.8%；母公司持有者应占溢利191.95亿元，同比增长105.2%；每股基本盈利6.72元，拟每10股派发现金股息15.7927元(含税)。截至收盘，暗盘交易显示报价30.42港元，较招股价16.66港元上涨82.59%，每手200股，不计手续费，每手赚2752港元。","market":"sh","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f8405c8fed8428607b7c9694048343b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417739.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1934453819.USD","BK1141","02729","LU0320764599.SGD","BK0216","LU2242644610.SGD","BK1179","02359","LU2328871848.SGD","09885","LU1997245177.USD","LU0052750758.USD","LU2488822045.USD","LU1997244956.HKD","HK0000500386.USD","BK1144","BK4585","LU1046422090.SGD","BK1583","HK0000252152.HKD","LU1808992512.USD","603259","LU1979443071.USD","BK1576","LU1969619763.USD","03931","LU2045819591.USD","HK0000252160.HKD","BK1594","BK1599","BK1197","LU2125910500.SGD","02632","BK4588","00581","LU1997245094.SGD","BK1163","LU2495084118.USD","00710","VXUS","LU0082770016.USD","BK1225","LU0456842615.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2621706669","title":"【财闻联播】药明康德2025年业绩出炉！中国银行：加强贵金属市场风险防范","url":"https://stock-news.laohu8.com/highlight/detail?id=2621706669","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621706669?lang=zh_cn&edition=full","pubTime":"2026-03-23 20:50","pubTimestamp":1774270200,"startTime":"0","endTime":"0","summary":"宏观动态“升级版”中欧出口管制对话机制第二次会议在京举行据商务部网站，2026年3月23日，中国商务部安全与管制局江前良局长与欧委会贸易总司雷东内副总司长在北京举行“升级版”中欧出口管制对话机制第二次会议，就出口管制领域各自关切进行深入、富有建设性的沟通，同意继续保持沟通交流，促进中欧产业链供应链稳定与畅通。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603233681180320.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0456842615.SGD","LU0588546209.SGD","IE00B19Z5X02.USD","LU1515016050.SGD","LU0320764599.SGD","LU2097828805.USD","LU2125910500.SGD","601988","LU2328871848.SGD","BK1231","LU1634259557.SGD","LU0708995583.HKD","LU0651947912.USD","LU1497734951.SGD","603259","LU1522347837.USD","BK0015","LU2488822045.USD","LU1282651121.HKD","LU1808992512.USD","LU2097828557.USD","LU1048588211.SGD","SG9999001093.SGD","BK1141","LU2097828714.EUR","LU1224444064.USD","IE00BQJZWZ67.USD","03988","LU2242644610.SGD","LU1282651048.USD","LU2097828631.EUR","LU1046422090.SGD","BK1560","03143","BK0028","LU1051768304.USD","BK0278","LU1997244956.HKD","LU1979443071.USD","LU0307460666.USD","LU0651946864.USD","BK1521","BK1583","BK0012","LU1051769294.HKD","LU1997245094.SGD","SG9999006597.SGD","LU2045819591.USD","02359","LU1497733557.USD"],"gpt_icon":0},{"id":"2621052737","title":"药明康德：关于续聘2026年度会计师事务所的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2621052737","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621052737?lang=zh_cn&edition=full","pubTime":"2026-03-23 20:29","pubTimestamp":1774268940,"startTime":"0","endTime":"0","summary":"药明康德：关于续聘2026年度会计师事务所的公告","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603233681168765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1969619763.USD","LU2125910500.SGD","LU2045819591.USD","BK1583","LU2495084118.USD","LU2328871848.SGD","LU2242644610.SGD","LU1997244956.HKD","LU1979443071.USD","LU1934453819.USD","LU1046422090.SGD","LU0320764599.SGD","LU1808992512.USD","BK1576","LU0052750758.USD","LU2488822045.USD","BK1141","02359","LU1997245094.SGD","LU0708995583.HKD","LU0456842615.SGD","BK0216","603259","LU1997245177.USD"],"gpt_icon":0},{"id":"2621774773","title":"药明康德：拟使用不超180亿元闲置自有资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621774773","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621774773?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:59","pubTimestamp":1774259987,"startTime":"0","endTime":"0","summary":"【药明康德：拟使用不超180亿元闲置自有资金进行现金管理】3月23日，药明康德(603259.SH)公告称，公司拟使用不超过180亿元(含)或其他等值外币的闲置自有资金进行现金管理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603233681052670.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603233681052670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2125910500.SGD","LU2045819591.USD","LU1997245177.USD","BK1583","LU0052750758.USD","LU1969619763.USD","LU2488822045.USD","LU0708995583.HKD","LU0456842615.SGD","LU1808992512.USD","603259","BK0216","LU0320764599.SGD","LU1979443071.USD","LU1934453819.USD","LU2495084118.USD","LU1046422090.SGD","LU2328871848.SGD","BK1141","BK1576","LU2242644610.SGD","LU1997244956.HKD","02359","LU1997245094.SGD"],"gpt_icon":0},{"id":"2621741617","title":"定调全年！药明康德(02359)预计2026年收入将达到513~530亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621741617","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621741617?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:59","pubTimestamp":1774259965,"startTime":"0","endTime":"0","summary":"药明康德用一份超预期的2025年成绩单和高达580亿元的在手订单，为2026年冲击500亿营收目标画出了一条清晰的增长曲线。药明康德对未来的乐观并非空穴来风，而是建立在2025年坚实的业绩基础之上。截至2025年末，药明康德持续经营业务在手订单已攀升至580亿元的历史峰值。这一庞大的“蓄水池”，几乎覆盖了公司2026年预计迈入的500亿元营收规模。八年时间内，从不足百亿跨越式五百亿营收规模，药明康德正持续领跑行业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1969619763.USD","LU2125910500.SGD","LU2045819591.USD","BK1583","LU2495084118.USD","LU2328871848.SGD","LU2242644610.SGD","LU1997244956.HKD","LU1979443071.USD","LU1934453819.USD","LU1046422090.SGD","LU0320764599.SGD","LU1808992512.USD","BK1576","LU0052750758.USD","LU2488822045.USD","BK1141","02359","LU1997245094.SGD","LU0708995583.HKD","LU0456842615.SGD","BK0216","603259","LU1997245177.USD"],"gpt_icon":0},{"id":"2621743127","title":"CRDMO战略兑现！药明康德全年营收454亿：以“史上最佳季度”回馈股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2621743127","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621743127?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:55","pubTimestamp":1774259722,"startTime":"0","endTime":"0","summary":"药明康德用一份全面超越指引的年度报告，为其坚定的CRDMO战略提供了最有力的注脚。公司2025年全年营收达454.56亿元，不仅创下历史新高，更在第四季度以126亿元的单季营收，刷新了“史上最佳季度”纪录，为高增长完美收官。基于创纪录的利润和其一贯现金分红政策和频率，药明康德预计2026年现金分红总额达到57.1亿元，创下历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"f8405c8fed8428607b7c9694048343b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","603259"],"gpt_icon":0},{"id":"2621779122","title":"药明康德(02359)将派发末期股息每10股15.7927元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621779122","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621779122?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:11","pubTimestamp":1774257105,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，将派发截至2025年12月31日止年度末期股息每10股15.7927元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2125910500.SGD","LU2045819591.USD","LU1997245177.USD","BK1583","LU0052750758.USD","LU1969619763.USD","LU2488822045.USD","LU0708995583.HKD","LU0456842615.SGD","LU1808992512.USD","603259","VIG","BK4588","BK0216","LU0320764599.SGD","LU1979443071.USD","LU1934453819.USD","LU2495084118.USD","LU1046422090.SGD","LU2328871848.SGD","BK4585","BK1141","BK1576","LU2242644610.SGD","LU1997244956.HKD","02359","LU1997245094.SGD"],"gpt_icon":0},{"id":"2621779994","title":"药明康德(02359)：建议重选执行董事、非执行董事、独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2621779994","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621779994?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:07","pubTimestamp":1774256829,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，根据公司章程，董事会建议提名重选下列董事：(i)李革博士、陈民章博士、杨青博士及张朝晖先生为第四届董事会执行董事;(ii)童小幪先生及吴亦兵博士为第四届董事会非执行董事。董事会建议提名重选卢韶华女士、俞卫博士、张新博士、詹智玲女士及冷雪松先生为第四届董事会独立非执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","LU2488822045.USD","BK1141","LU1979443071.USD","603259","LU1969619763.USD","LU2045819591.USD","BK1583","LU1997245177.USD","LU2125910500.SGD","LU0456842615.SGD","LU1997244956.HKD","LU2495084118.USD","02359","LU1808992512.USD","LU0708995583.HKD","LU1046422090.SGD","LU2328871848.SGD","LU0052750758.USD","BK0216","LU1934453819.USD","LU2242644610.SGD","LU1997245094.SGD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2621776257","title":"药明康德(02359)：建议变更注册资本为29.84亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621776257","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621776257?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:54","pubTimestamp":1774256066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，于2025年9月30日及2025年10月10日，公司因H股可转债转股而增发H股股份合计3225.04万股。根据上述股份变动情况，董事会建议将本公司注册资本由人民币29.52亿元(分为29.52亿股股份)变更为人民币29.84亿元(分为29.84亿股股份)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0456842615.SGD","LU0320764599.SGD","LU2125910500.SGD","LU2328871848.SGD","BK0216","LU0708995583.HKD","LU1997245177.USD","603259","LU2488822045.USD","LU1808992512.USD","BK1141","LU2495084118.USD","LU2242644610.SGD","LU0052750758.USD","LU1046422090.SGD","LU1969619763.USD","LU1934453819.USD","LU1997244956.HKD","LU1979443071.USD","LU1997245094.SGD","BK1583","LU2045819591.USD","02359","BK1576"],"gpt_icon":0},{"id":"1112442591","title":"药明康德上调股份回购价格上限至每股不超过114.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112442591","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112442591?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:52","pubTimestamp":1774255926,"startTime":"0","endTime":"0","summary":"药明康德宣布，对公司股份回购方案中回购价格的上限进行调整。根据最新公告，回购价格上限已调整为每股不超过人民币114.15元。此次调整旨在优化公司资本结构，提升股东价值，并体现管理层对公司未来发展的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","BK1141","LU2242644610.SGD","LU1997245094.SGD","LU1997244956.HKD","LU0708995583.HKD","LU0456842615.SGD","BK1583","LU2488822045.USD","LU0052750758.USD","LU1979443071.USD","02359","LU2125910500.SGD","LU0320764599.SGD","LU2495084118.USD","LU1808992512.USD","LU2328871848.SGD","LU2045819591.USD","603259","LU1046422090.SGD","BK1576","LU1969619763.USD","LU1934453819.USD","LU1997245177.USD"],"gpt_icon":0},{"id":"1190304564","title":"药明康德：2025年营收454.56亿元，归母净利润191.95亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190304564","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190304564?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:49","pubTimestamp":1774255766,"startTime":"0","endTime":"0","summary":"3月23日，$药明康德(02359)$：2025年公司实现营业收入人民币454.56亿元，同比上升15.8%；实现归母净利润人民币191.95亿元，同比上升105.2%。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f8405c8fed8428607b7c9694048343b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"药明康德：2025年营收454.56亿元，归母净利润191.95亿元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046422090.SGD","LU2495084118.USD","LU1934453819.USD","LU2488822045.USD","LU1969619763.USD","BK1583","LU1997244956.HKD","LU0320764599.SGD","603259","LU1997245177.USD","LU1979443071.USD","BK1576","02359","LU1997245094.SGD","LU0052750758.USD","LU2045819591.USD","LU0456842615.SGD","BK1141","LU0708995583.HKD","LU2242644610.SGD","LU1808992512.USD","LU2328871848.SGD","LU2125910500.SGD","BK0216"],"gpt_icon":0},{"id":"2620414038","title":"药明康德涨幅扩大至4.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620414038","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620414038?lang=zh_cn&edition=full","pubTime":"2026-03-17 10:59","pubTimestamp":1773716350,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月17日，药明康德涨幅扩大至4.9%，报112.7港元，成交额1.5亿港元，总市值3354亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603173674291884.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674291884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","BK1141","02359","LU0052750758.USD","LU2495084118.USD","LU1997245177.USD","LU1934453819.USD","LU1969619763.USD","LU0708995583.HKD","LU1997244956.HKD","603259","BK0216","LU2125910500.SGD","LU1046422090.SGD","LU0320764599.SGD","LU2045819591.USD","LU2488822045.USD","BK1583","LU1979443071.USD","LU0456842615.SGD","LU2328871848.SGD","LU1808992512.USD","LU1997245094.SGD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2619785871","title":"每周股票复盘：药明康德（603259）将召开董事会审议2025年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2619785871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619785871?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:49","pubTimestamp":1773514148,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，药明康德报收于90.87元，较上周的93.3元下跌2.6%。本周，药明康德3月11日盘中最高价报94.95元。药明康德当前最新总市值2711.34亿元，在医疗服务板块市值排名1/51，在两市A股市值排名47/5190。本周关注点来自公司公告汇总：药明康德将于2026年3月23日召开董事会会议，审议2025年度全年业绩及建议末期股息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0708995583.HKD","LU0320764599.SGD","BK1141","LU1046422090.SGD","LU1997245094.SGD","LU1934453819.USD","BK1583","LU2125910500.SGD","LU0052750758.USD","LU2328871848.SGD","BK0216","LU2488822045.USD","603259","BK1576","02359","LU1969619763.USD","LU1997244956.HKD","LU1997245177.USD","LU2242644610.SGD","LU2495084118.USD","LU1808992512.USD","LU0456842615.SGD","LU1979443071.USD","LU2045819591.USD"],"gpt_icon":0},{"id":"1131679409","title":"摩根大通增持药明康德H股 持股比例从7.14%升至8.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131679409","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131679409?lang=zh_cn&edition=full","pubTime":"2026-03-04 18:13","pubTimestamp":1772619195,"startTime":"0","endTime":"0","summary":"根据香港交易所最新披露的数据，摩根大通于2月26日对药明康德H股（股份代号：02359）的持股比例出现显著变动。该机构持有的多头头寸从原先的7.14%提升至8.32%，显示出其对药明康德发展前景的持续看好。\n此次增持动作进一步巩固了摩根大通作为药明康德重要股东的地位。持股比例的提升往往被市场解读为机构投资者对企业基本面和未来成长潜力的积极预期。药明康德作为全球领先的医药研发外包服务平台，其业务布局和技术实力一直受到资本市场的广泛关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","BK1583","LU1997245177.USD","LU1808992512.USD","LU2242644610.SGD","LU2328871848.SGD","LU1934453819.USD","LU1997245094.SGD","603259","LU1046422090.SGD","LU2045819591.USD","LU1997244956.HKD","LU1969619763.USD","LU2125910500.SGD","LU1979443071.USD","BK0216","BK1576","02359","LU0052750758.USD","LU2495084118.USD","LU0320764599.SGD","LU2488822045.USD","BK1141","LU0456842615.SGD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774395031464,"stockEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":-0.0808},{"period":"3month","weight":0.0315},{"period":"6month","weight":-0.1247},{"period":"1year","weight":0.4256},{"period":"ytd","weight":0.0335}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.0492},{"period":"3month","weight":-0.0151},{"period":"6month","weight":0.0073},{"period":"1year","weight":0.1517},{"period":"ytd","weight":-0.0221}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"251250人(较上一季度减少15.59%)","perCapita":"9843股","listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","registeredCapital":"298375万元","survey":" 无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务、其他业务。","listedPrice":21.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,603259,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}